Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.46 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30556227 | 1.00 | FDPS (0.46) | FDPSGGPS1AKR1B1CES2GPR84 | |
| SCHEMBL30556226 | 1.00 | FDPS (0.46) | FDPSGGPS1AKR1B1CES2GPR84 | |
| SCHEMBL1053801 | 0.98 | FDPS (0.48) | FDPSGGPS1CES2GPR84PPARG | |
| SCHEMBL7652875 | 0.98 | FDPS (0.48) | FDPSGGPS1CES2GPR84PPARG | |
| SCHEMBL28253694 | 0.98 | FDPS (0.48) | FDPSGGPS1CES2GPR84PPARG | |
| SCHEMBL1052609 | 0.98 | FDPS (0.48) | FDPSGGPS1CES2GPR84PPARG | |
| SCHEMBL5718512 | 0.98 | FDPS (0.48) | FDPSGGPS1CES2GPR84PPARG | |
| SCHEMBL17986647 | 0.98 | FDPS (0.48) | FDPSGGPS1CES2GPR84PPARG | |
| SCHEMBL453153 | 0.98 | FDPS (0.48) | FDPSGGPS1CES2GPR84PPARG | |
| SCHEMBL28374981 | 0.95 | FDPS (0.47) | FDPSGGPS1CES2GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116573981-B | Resolution method of beta receptor blocker raceme medicine | 中南大学 | 2025-05-06 | — | — | CN | disclosed |
| CN-117164526-A | 2- (piperazine-2-yl) acetonitrile derivative, and preparation method and application thereof | 苏州泽璟生物制药股份有限公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-113582912-B | Preparation method of optically pure lobelin hydrochloride and enantiomer thereof | 广东药科大学 | 2023-09-01 | — | — | CN | disclosed |
| CN-116573981-A | Resolution method of beta receptor blocker raceme medicine | 中南大学 | 2023-08-11 | — | — | CN | disclosed |
| EP-1814852-B1 | HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS | CATALYST BIOSCIENCES INC (US) | 2016-01-20 | — | — | EP | disclosed |
| CN-1680326-A | Pharmaceutical compositions and methods for use | TARGACEPT INC (US) | 2005-10-12 | — | — | CN | disclosed |
| CN-1680326-A | Pharmaceutical compositions and methods for use | TARGACEPT INC (US) | 2005-10-12 | — | — | CN | disclosed |
| EP-1311265-B1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | TARGACEPT INC (US) | 2004-12-29 | — | — | EP | disclosed |
| EP-1311265-B1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | TARGACEPT INC (US) | 2004-12-29 | — | — | EP | disclosed |
| US-6743812-B1 | 2,3-DIACYLTARTARIC ACID SALTS OF E-METANICOTINE; NERVOUS SYSTEM DISORDERS; AGONISTS OF SPECIFIC NICOTINIC RECEPTOR SUBTYPES | TARGACEPT, INC. | 2004-06-01 | — | — | US | disclosed |
| EP-1311265-A2 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | Targacept, Inc. (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002005798-A3 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | TARGACEPT INC (US) | 2003-03-13 | — | — | WO | disclosed |
| US-6432954-B1 | CENTRAL NERVOUS SYSTEM DISORDERS | TARGACEPT, INC. | 2002-08-13 | — | — | US | disclosed |
| US-6432954-B1 | CENTRAL NERVOUS SYSTEM DISORDERS | TARGACEPT, INC. | 2002-08-13 | — | — | US | disclosed |
| WO-2002005801-A3 | COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE | TARGACEPT INC (US) | 2002-08-08 | — | — | WO | disclosed |
| WO-2002005801-A2 | COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE | TARGACEPT, INC. (US) | 2002-01-24 | — | — | WO | disclosed |
| WO-2002005801-A2 | COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE | TARGACEPT, INC. (US) | 2002-01-24 | — | — | WO | disclosed |
| WO-2002005798-A2 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | TARGACEPT, INC. (US) | 2002-01-24 | — | — | WO | disclosed |
| WO-2002005798-A2 | PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | TARGACEPT, INC. (US) | 2002-01-24 | — | — | WO | disclosed |
| WO-1991010372-A1 | LOW CALORIE NUTS WITH THE ORGANOLEPTIC CHARACTER OR FULL FAT NUTS | NABISCO, INC. (US) | 1991-07-25 | — | — | WO | disclosed |